Peter Lutwyche
Director/Board Member at Renaissance BioScience Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael McElhaugh | M | 50 | 10 years | |
| John Husnik | M | 53 |
Renaissance BioScience Corp.
 Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Renaissance BioScience Corp. is a bioengineering private company based in Vancouver, Canada. The Canadian company specializes in microbial bioengineering innovation and develop market-ready, functional microorganisms for various industries such as agriculture, food and beverage, health, and energy. Renaissance BioScience's proprietary strain collections, breeding knowledge, fermentation, and screening platforms are used to engineer and deliver unique, scalable solutions for industry and academia. The company's technologies have created products that impact millions of people worldwide, including acrylamide-reducing yeast for safer foods and H2S-preventing wine yeast. More information about the Renaissance group of companies is available on their website. The company was founded by John Husnik and Maurice Boucher, and John Husnik has been the CEO since incorporation. | - |
| Richard Henriques | M | 68 | 10 years | |
| Daniel Burgess | M | 62 | 7 years | |
| Keith Manchester | M | 55 | 9 years | |
| Victor Stanley Dusik | M | 72 |
Renaissance BioScience Corp.
Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Renaissance BioScience Corp. is a bioengineering private company based in Vancouver, Canada. The Canadian company specializes in microbial bioengineering innovation and develop market-ready, functional microorganisms for various industries such as agriculture, food and beverage, health, and energy. Renaissance BioScience's proprietary strain collections, breeding knowledge, fermentation, and screening platforms are used to engineer and deliver unique, scalable solutions for industry and academia. The company's technologies have created products that impact millions of people worldwide, including acrylamide-reducing yeast for safer foods and H2S-preventing wine yeast. More information about the Renaissance group of companies is available on their website. The company was founded by John Husnik and Maurice Boucher, and John Husnik has been the CEO since incorporation. | - |
| Maurice Boucher | M | 68 |
Renaissance BioScience Corp.
Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Renaissance BioScience Corp. is a bioengineering private company based in Vancouver, Canada. The Canadian company specializes in microbial bioengineering innovation and develop market-ready, functional microorganisms for various industries such as agriculture, food and beverage, health, and energy. Renaissance BioScience's proprietary strain collections, breeding knowledge, fermentation, and screening platforms are used to engineer and deliver unique, scalable solutions for industry and academia. The company's technologies have created products that impact millions of people worldwide, including acrylamide-reducing yeast for safer foods and H2S-preventing wine yeast. More information about the Renaissance group of companies is available on their website. The company was founded by John Husnik and Maurice Boucher, and John Husnik has been the CEO since incorporation. | 11 years |
| Morris Chen | M | 69 |
Renaissance BioScience Corp.
Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Renaissance BioScience Corp. is a bioengineering private company based in Vancouver, Canada. The Canadian company specializes in microbial bioengineering innovation and develop market-ready, functional microorganisms for various industries such as agriculture, food and beverage, health, and energy. Renaissance BioScience's proprietary strain collections, breeding knowledge, fermentation, and screening platforms are used to engineer and deliver unique, scalable solutions for industry and academia. The company's technologies have created products that impact millions of people worldwide, including acrylamide-reducing yeast for safer foods and H2S-preventing wine yeast. More information about the Renaissance group of companies is available on their website. The company was founded by John Husnik and Maurice Boucher, and John Husnik has been the CEO since incorporation. | - |
| Karen Sims | M | 53 | 7 years | |
| Michael Sofia | M | 66 | 9 years | |
| Blair Jordan | M | 55 |
Renaissance BioScience Corp.
Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Renaissance BioScience Corp. is a bioengineering private company based in Vancouver, Canada. The Canadian company specializes in microbial bioengineering innovation and develop market-ready, functional microorganisms for various industries such as agriculture, food and beverage, health, and energy. Renaissance BioScience's proprietary strain collections, breeding knowledge, fermentation, and screening platforms are used to engineer and deliver unique, scalable solutions for industry and academia. The company's technologies have created products that impact millions of people worldwide, including acrylamide-reducing yeast for safer foods and H2S-preventing wine yeast. More information about the Renaissance group of companies is available on their website. The company was founded by John Husnik and Maurice Boucher, and John Husnik has been the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Julia G. Levy | M | 89 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 21 years |
| Mark J. Murray | M | 75 | 11 years | |
| Vivek Ramaswamy | M | 38 | 3 years | |
| Timothy M. Ruane | M | 59 | 3 years | |
| Elizabeth Howard | M | 70 | 7 years | |
| Ken Galbraith | M | 61 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 19 years |
| Michael Jeffrey Abrams | M | 68 | 8 years | |
| Koert VandenEnden | M | 45 | 3 years | |
| C. Boyd Clarke | M | 74 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 9 years |
| Bruce Cousins | M | 63 | 5 years | |
| Donald Jewell | M | - | 7 years | |
| Sukhi Jagpal | M | 50 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 12 years |
| Paul Hastings | M | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 years |
| Ronald Ian Lennox | M | 71 | 4 years | |
| Lawrence John Wood | M | 87 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Bruce Carter | M | 80 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 years |
| Ian John Massey | M | 73 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 years |
| Arthur M. Bruskin | M | - | 4 years | |
| Dori Christine Assaly | F | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Frank Karbe | M | 55 | 8 years | |
| Dan Kisner | M | 77 | - | |
| Robert Lee Butchofsky | M | 62 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 14 years |
| Peggy Phillips | F | 70 | 1 years | |
| Cameron R. Nelson | M | 58 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 12 years |
| William T. Symonds | M | 56 | 4 years | |
| Peter Hnik | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 7 years |
| Ian Mortimer | M | 48 | 16 years | |
| Mark Kowalski | M | 69 | 3 years | |
| Tom Frohlich | M | 48 | 2 years | |
| Jennifer Kaufman-Shaw | M | 74 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 10 years |
| Patrick T. Higgins | M | 66 | - | |
| Alexandra Mancini | F | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 7 years |
| Wajida Leclerc | F | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 10 years |
| James Heyes | M | - | 3 years | |
| Sandra Rose MacKay | F | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 years |
| Martin A. Kaufman | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 years |
| Jodi Regts | F | - | 3 years | |
| David Granville | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 years |
| Lana Janes | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Peter O'Callaghan | M | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 1 years |
| Diane Gardiner | F | - | 2 years | |
| Helia Baradarani | F | - | - | |
| K. Michael Forrest | M | 80 | 3 years | |
| James W. Hudson | M | - | 3 years | |
| Paul Brennan | M | - | 5 years | |
| Ron D. Henriksen | M | 85 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 10 years |
| Michael R. Duncan | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Therese Hayes | F | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| James Redenbarger | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Daniel J. Wattier | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Janet Grove | F | 57 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Michael Patrick Smith | M | 55 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 2 years |
| Alan C. Mendelson | M | 76 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 years |
| Gary E. Frashier | M | 86 | 3 years | |
| Michael John Doty | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Philip B. Livingston | M | 66 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Mohammad Azab | M | 68 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 8 years |
| Edwin Levy | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 14 years |
| Alain H. Curaudeau | M | 67 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 8 years |
| William Newell | M | 66 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 3 years |
| George J. Vuturo | M | 74 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 1 years |
| Adam Daniel Cutler | M | 50 | 2 years | |
| Richard R. Vietor | M | 81 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Eric Adams | M | 61 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 years |
| R. MacKay-Dunn | M | 73 | - | |
| Alexander R. Lussow | M | 62 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 8 years |
| Ian MacLachlan | M | - | 6 years | |
| Maurice Wolin | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Jean Jen | F | 37 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 44 | 55.00% |
| United States | 37 | 46.25% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Lutwyche
- Personal Network
